"Pancreatic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Descriptor ID |
D010190
|
| MeSH Number(s) |
C04.588.274.761 C04.588.322.475 C06.301.761 C06.689.667 C19.344.421
|
| Concept/Terms |
Pancreatic Neoplasms- Pancreatic Neoplasms
- Neoplasm, Pancreatic
- Pancreatic Neoplasm
- Pancreas Neoplasms
- Neoplasm, Pancreas
- Neoplasms, Pancreas
- Pancreas Neoplasm
- Neoplasms, Pancreatic
Cancer of Pancreas- Cancer of Pancreas
- Pancreas Cancers
- Pancreas Cancer
- Cancer, Pancreas
- Cancers, Pancreas
- Pancreatic Cancer
- Cancer, Pancreatic
- Cancers, Pancreatic
- Pancreatic Cancers
- Cancer of the Pancreas
|
Below are MeSH descriptors whose meaning is more general than "Pancreatic Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Pancreatic Neoplasms".
This graph shows the total number of publications written about "Pancreatic Neoplasms" by people in this website by year, and whether "Pancreatic Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 1 | 1 | 2 |
| 1999 | 3 | 1 | 4 |
| 2000 | 2 | 1 | 3 |
| 2001 | 6 | 0 | 6 |
| 2002 | 6 | 6 | 12 |
| 2003 | 1 | 1 | 2 |
| 2004 | 5 | 1 | 6 |
| 2005 | 21 | 3 | 24 |
| 2006 | 10 | 2 | 12 |
| 2007 | 17 | 1 | 18 |
| 2008 | 19 | 3 | 22 |
| 2009 | 15 | 3 | 18 |
| 2010 | 17 | 2 | 19 |
| 2011 | 20 | 4 | 24 |
| 2012 | 11 | 2 | 13 |
| 2013 | 21 | 4 | 25 |
| 2014 | 21 | 1 | 22 |
| 2015 | 18 | 2 | 20 |
| 2016 | 28 | 3 | 31 |
| 2017 | 21 | 4 | 25 |
| 2018 | 19 | 1 | 20 |
| 2019 | 29 | 3 | 32 |
| 2020 | 27 | 3 | 30 |
| 2021 | 7 | 1 | 8 |
| 2022 | 24 | 0 | 24 |
| 2023 | 19 | 0 | 19 |
| 2024 | 26 | 3 | 29 |
| 2025 | 24 | 1 | 25 |
| 2026 | 14 | 2 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pancreatic Neoplasms" by people in Profiles.
-
All Together Now: Standardization of Nomenclature for Neuroendocrine Neoplasms across Multiple Organs. Clin Lab Med. 2026 Sep; 46(3):577-606.
-
Krenning score enhances integrated biomarker models for survival prediction in PRRT-treated GEP-NET: a retrospective cohort study. Cancer Imaging. 2026 Aug 25; 26(1).
-
Microenvironmental arginine restriction sensitizes pancreatic cancers to polyunsaturated fatty acids by suppression of lipid synthesis. Elife. 2026 Aug 05; 14.
-
Engineered probiotic Bifidobacterium for tumor-targeted pancreatic cancer therapy. Sci Adv. 2026 Jul 24; 12(30):eadz1388.
-
Isolation of Bacteria and Fungi from Human Pancreatic Tumors and Duodenum. Gut Microbes. 2026 Dec 31; 18(1):2695522.
-
The Genetics and Screening of Gastroenteropancreatic Neuroendocrine Tumors and Adrenal Tumors. Surg Clin North Am. 2026 Aug; 106(4):555-569.
-
Tissue-specific tolerance mechanisms and lymph node co-drainage shape T cell immunity in the upper digestive system and pancreatic cancer progression. Cell Rep. 2026 May 26; 45(5):117324.
-
Mitochondrial double-stranded RNA fuels pancreatic cancer growth via RIG-I/TLR3 inflammation. Proc Natl Acad Sci U S A. 2026 May 05; 123(18):e2528281123.
-
Non-coding RNAs as biomarkers and therapeutic targets in pancreatic cancer: Clinical implications and translational perspectives. Biomed Pharmacother. 2026 Jun; 199:119394.
-
The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. Mol Cell. 2026 Apr 02; 86(7):1260-1274.e4.